Differences in the clinical characteristics and 1-year mortality rates of patients with dermatomyositis with anti-jo-1 and anti-mda5 antibodies

HIGHLIGHTS

• who: Antibodies and colleagues from the Division of Allergy, Immunology and Rheumatology, Department of Internal Medicine, Changhua Christian Hospital, Changhua, Taiwan Graduate Institute of Statistics and Information Science, National Changhua University of Education, Changhua, Taiwan have published the research: Differences in the Clinical Characteristics and 1-Year Mortality Rates of Patients with Dermatomyositis with anti-Jo-1 and anti-MDA5 Antibodies, in the Journal: Journal of Immunology Research of 27/Oct/2022
• what: This study investigated differences in the clinical characteristics and prognosis of patients with anti-Jo-1 Abs and anti-MDA5 Abs with . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.